YEEDI Launches M16 Infinity, an Award-Winning Robot Vacuum Built on the Success of the M14 PLUS
SAN FRANCISCO, March 13, 2026 /PRNewswire/ -- YEEDI today announced the launch of the M16 Infinity, a next-generation robot vacuum designed to deliver stronger cleaning performance, quieter operation, and easier maintenance. M16 Infinity The launch...
Sigenergy Inaugurates Nantong Smart Energy Center, Pioneering "AI in All" Strategy and Next-Gen Energy Portfolio
NANTONG, China, March 13, 2026 /PRNewswire/ -- Sigenergy today officially inaugurated the Sigenergy Nantong Smart Energy Center in Nantong, Jiangsu Province, China, marking a new milestone in the company's global development. The event brought...
NATURE'S MIRACLE HOLDING INC. PROVIDES INVESTOR HOTLINE
ONTARIO, Calif., March 13, 2026 /PRNewswire/ -- Nature's Miracle Holding Inc. ("Nature's Miracle" or the "Company") (OTCQB: NMHI), a leader in controlled environment agriculture, today announced that it is setting up an investor hotline at...
Esaote at EAU 2026: Introducing Exclusive PAM Technology to Advance Precision in Urological Imaging
The technology is available on the new MyLab™E85 GTS Edition that will be showcased together with the brand new MyLab™C30 GTS ultrasound system at the Esaote booth LONDON, March 13, 2026 /PRNewswire/ -- Esaote Group, a leading Italian innovator in...
"Hello, Beijing! Diplomatic Memoirs in the Capital" Video Series Launched at London Book Fair 2026
LONDON, March 13, 2026 /PRNewswire/ -- The launch event for the "Hello, Beijing! Diplomatic Memoirs in the Capital" video series was successfully held on March 11, 2026, at the London Book Fair. Premiere of the Video Series“Hello, Beijing!...
KuCoin Launches Stock Index Perpetual Contracts, Expanding 24/7 Cross-Asset Access
PROVIDENCIALES, Turks and Caicos Islands, March 13, 2026 /PRNewswire/ -- KuCoin, a leading global crypto platform built on trust, today announced the launch of its Stock Index Perpetual Contracts, with the first batch of contracts scheduled for...
Everest Medicines' Licensing Partner NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study
VIS-101, purpose-designed to be best-in-class for retinal vascular diseases, is a tetravalent, dual VEGF-A X ANG-2 inhibitor Topline Phase 2a data show VIS-101 provides rapid, robust and durable treatment responses in wet AMD VIS-101 demonstrated...
From R&D Self-Reliance to Standard Reshaping: How Chinese Brand BABI Decodes Global Photoprotection Challenges and Reconstructs Sunscreen Logic with Patented Technology
HANGZHOU, China, March 13, 2026 /PRNewswire/ -- Over the past decades, the evolution of sun protection has been closely tied to humanity's fight against skin photoaging. Despite the widespread awareness of sun protection, market feedback reveals a...